However, biologic treatment (anti-TNF therapy) was less common among patients with flares compared to those without (7.2% vs. 23.2%; p = 0.003), while also a lower percentage of patients with flares had been previously vaccinated for COVID-19 (81.1% vs. 99.1%; p < 0.001). The gene discussed is TNF; the disease is COVID-19.